Faraday Future, led by Jia Yueting, has invested in QLGN through a $41 million PIPE deal in collaboration with the Sign Foundation to launch its crypto assets business.

robot
Abstract generation in progress

On September 20, Faraday Future (NASDAQ: FFAI) announced today that it will strategically invest in Qualigen Therapeutics(NASDAQ: QLGN) through a $41 million PIPE transaction. The latter will be renamed CXC10 and will transition to a crypto and Web3 business platform. The investment lineup is strong, including not only Faraday Future and Jia Yueting personally but also Sign, a blockchain technology company that builds on-chain public infrastructure for governments and enterprises globally, providing secure solutions ranging from digital identification to Token distribution.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)